Latest / Stock Movers / Delta Rises, Novo Falls, MP Materials After WSJ Report
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio News, The.
- 0:08Speaker 2: Stock Movers report, your roundup of companies making moves in
- 0:12Speaker 2: the stock market, harnessing the power of Bloomberg data.
- 0:16Speaker 3: Let's take a look at some of the stocks on
- 0:17Speaker 3: the move today on Paul Sweeney alongside Scarlatfu and we're
- 0:20Speaker 3: joined by.
- 0:20Speaker 4: Bloomberg's Bailey Lipshaltz Billybody looking up.
- 0:23Speaker 3: Yeah, some of the best performing stocks in the S
- 0:25Speaker 3: and P five hundred this morning are in the airline space.
- 0:28Speaker 3: This comes after Delta Air ticker dl reported earnings that
- 0:32Speaker 3: beat expectations and kind of talked up guidance for fourth
- 0:36Speaker 3: quarter and some of the strength they expect to continue
- 0:38Speaker 3: to see into twenty twenty six. So Delta Air shares
- 0:41Speaker 3: up about five and a half percent. Also keeping eye,
- 0:44Speaker 3: as I mentioned, United Health or United Airlines excuse me,
- 0:46Speaker 3: up close to four percent.
- 0:47Speaker 4: Alaska Air trading higher.
- 0:49Speaker 3: So this comes after management a bit more optimistic not
- 0:52Speaker 3: only on business demand but broader travel spending, saying that
- 0:55Speaker 3: they expect to see potentially a record fourth quarter for
- 0:58Speaker 3: the company.
- 0:59Speaker 4: People travel for holidays.
- 1:01Speaker 3: But also a thing to keep in mind, as Bloomberg
- 1:03Speaker 3: had reported earlier this morning, we're starting to see some
- 1:05Speaker 3: of those cracks showing up with the government shutdown, what
- 1:08Speaker 3: that means for the FAA and how that could impact it.
- 1:11Speaker 3: So management was asked about that, basically saying that, you know,
- 1:14Speaker 3: if this is extended, that could impact fourth quarter demand,
- 1:17Speaker 3: but for now they're not really seeing.
- 1:19Speaker 1: That show up absolutely all right, So Delta a clear
- 1:22Speaker 1: winner here. You're also keeping an eye on the pharmer space,
- 1:25Speaker 1: and there's some M and a yeah, m.
- 1:26Speaker 3: And a Novo Nordisk acquiring a Caro Therapeutics. So Novo
- 1:30Speaker 3: ADRs ticker ENVO down about one percent and a care
- 1:34Speaker 3: of Therapeutics up more than sixteen percent, trading about fifty
- 1:37Speaker 3: four dollars, So this is a four point seven billion
- 1:40Speaker 3: dollars deal that could be bumped up if the company's
- 1:44Speaker 3: drug is successful. So not only is there a fifty
- 1:47Speaker 3: four dollars cash component, there's also a contingent value right Basically,
- 1:50Speaker 3: Novo Nordisk trying to build out its weight loss opportunities.
- 1:55Speaker 3: A Caro is not in the weight loss space, but
- 1:57Speaker 3: treating the deadly liver disease is mash, not the TV show,
- 2:02Speaker 3: So this is something that could build out their portfolio.
- 2:05Speaker 3: Again looking through some of the quick analyst reactions, basically
- 2:08Speaker 3: saying Novo has a lot of wood to chop to
- 2:10Speaker 3: try to get back to where it was trading before.
- 2:12Speaker 3: Management talking up this acquisition saying that they want to
- 2:14Speaker 3: be able to treat not only the weight loss space,
- 2:16Speaker 3: but also other issues related to the liver fatty liver
- 2:19Speaker 3: as well.
- 2:20Speaker 1: Yeah, I'm looking at this and apparently MASH is one
- 2:22Speaker 1: of the most prevalent obesity related to comorbidities to so
- 2:27Speaker 1: you know, it's rounding outs portfolio in a very interesting
- 2:29Speaker 1: holistic way.
- 2:29Speaker 4: It all fits into that argument.
- 2:31Speaker 3: And really this does come after Novo's drug that they
- 2:34Speaker 3: were developing and the space failed, so this is kind
- 2:36Speaker 3: of trying to replace that. As we see again, not
- 2:39Speaker 3: only are some of the shot weight loss shots we
- 2:41Speaker 3: go vi ozepic being pretty successful, there is uncertainty again
- 2:44Speaker 3: with potential pills and also once those things lose their patents,
- 2:48Speaker 3: so trying to stay ahead of the game and trying
- 2:50Speaker 3: to build it out. This again, according to analyst expectations,
- 2:53Speaker 3: could be a billions upon billions of dollars of potential revenue,
- 2:57Speaker 3: so a big purchase for Novo Nordice. But again just
- 3:00Speaker 3: a small kind of step in the direction.
- 3:01Speaker 4: For the company. All Right, one more Walkware. Yeah, keep
- 3:04Speaker 4: an eye on MP materialsticker.
- 3:06Speaker 3: MP up about five percent, seeing a rally across US
- 3:09Speaker 3: listed rare earth and critical mineral stocks. This comes after
- 3:13Speaker 3: reports that China is going to apply a default ban
- 3:17Speaker 3: on defense sector exports of those materials, so investors piling
- 3:20Speaker 3: into companies that are tied to the US government trying
- 3:22Speaker 3: to secure some of those non China supply chains for
- 3:25Speaker 3: rare earths.
- 3:26Speaker 2: The Stock Movers report from Bloomberg Radio. Check back with
- 3:30Speaker 2: us throughout the day for the latest roundup of companies
- 3:33Speaker 2: making news on Wall Street and for the latest market
- 3:36Speaker 2: moving headlines. Listen to Bloomberg Radio Live. Catch us on YouTube,
- 3:41Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 3:44Speaker 2: the Bloomberg Business app.